Online Activities
Connect & Knowledge-share with your Peers
Our regular Online Activities keep you connected to the conversation, through our Monthly Thought Leaders Online and Webinars from industry experts and cutting-edge solution providers.
Upcoming R&D Spotlights
-
R&D Spotlight:
Advanced Analytical Strategies for NextGen Antibodies
24 September 2026 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
Computational Antibody Discovery
02 December 2026 | Online, BST (UTC+1)
-
R&D Spotlight:
Scaling Up CGT Manufacturing
03 December 2026 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
Analytical Development & QC Strategies for Advanced CGTs
4 March 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
Computational & AI-Guided Antibody Discovery
11 May 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
Scaling Up CGT Manufacturing
6 July 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
Addressing ADC Toxicity Challenges
9 September 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
Biomarkers for Translational Development Across Modalities
27 October 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
-
R&D Spotlight:
New Approaches & Techniques to Cell Therapy Development
2 December 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
24 Sep 2026 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Advanced Analytical Strategies for NextGen Antibodies
22 Oct 2026 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Advancing Formulation Development
29 Oct 2026 | Online, 15:00 London | 16:00 Paris | 10:00 New York
Advancing AI-Driven Computational Pathology
17 Nov 2026 | Online, Online, 15:00 London | 16:00 Paris | 10:00 New York
Novel Approaches to Target Identification & Validation
19 Nov 2026 | Online, GMT (UTC+0)
Proteomic Biomarkers Insights
02 Dec 2026 | Online, BST (UTC+1)
Computational Antibody Discovery
03 Dec 2026 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Scaling Up CGT Manufacturing
11 Feb 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
AI in Drug Discovery
18 Feb 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Integrated Approaches to Multi-Omics
4 Mar 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Analytical Development & QC Strategies for Advanced CGTs
16 Mar 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Nasal & Inhaled Biotherapeutics
22 Apr 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Liquid Biopsies in Early Detection & Patient Monitoring
11 May 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Computational & AI-Guided Antibody Discovery
9 Jun 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
How NAMs Are Transforming Drug Discovery
25 Jun 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
AI in Precision Medicine Development
6 Jul 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Scaling Up CGT Manufacturing
9 Sep 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Addressing ADC Toxicity Challenges
29 Sep 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Delivering Therapies Across the Blood-Brain Barrier
23 Sep 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Unlocking the Potential of Foundation Models in Computational Pathology & Spatial Biology
14 Oct 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Advancing Biomarker-Driven Clinical Trials with AI
20 Oct 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Next-Generation Drug Screening: AI, Automation & Human-Relevant Models
27 Oct 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Biomarkers for Translational Development Across Modalities
9 Nov 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Precision Neuroscience: Biomarkers And Patient Stratification
2 Dec 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
New Approaches & Techniques to Cell Therapy Development
8 Dec 2027 | Online, 14:00 London | 15:00 Paris | 09:00 New York
Scaling Spatial Biology Across Research and Clinical Development
Upcoming Activities
Advances in Protein Expression and Production
AGENDA OVERVIEW
Tuesday, 6 October | 3:00–3:40 pm UK | 10:00-10:40 am EST
The session will explore key themes including:
- Current challenges in protein expression, purification, and quality control
- Why protein production remains a key bottleneck in drug discovery
- How improved data capture can support future machine learning models
- Lessons from difficult-to-express proteins and complex target classes
- How initiatives such as Target 2035 can help accelerate discovery
- Future opportunities for predictive models in protein production success
Confirmed panellists
- Kim Remans — Head of Protein Expression and Purification Core Facility, European Molecular Biology Laboratory
- Lovisa Holmberg Schiavone — Protein Sciences, Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca
- Evgeny Tankhilevich — European Bioinformatics Institute, EMBL-EBI, Wellcome Genome Campus
- Christopher Cooper - School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey
Moderated by Nicola Burgess-Brown — Professorial Research Fellow in Protein Science, University College London; Chief Operating Officer, Protein Sciences, Structural Genomics Consortium
You can catch up on our past NextGen Biomed webinar recordings on our Resources page.

Unlock the Latest News and Insights
Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.
